By: IPP Bureau
Last updated : June 08, 2026 7:09 am
Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy
Lupin Manufacturing Solutions (LMS) has appointed Eduardo Jule as its Chief Commercial Officer, reinforcing the company's leadership team as it continues to expand its global Contract Development and Manufacturing Organization (CDMO) and Active Pharmaceutical Ingredient (API) businesses.
Eduardo brings more than two decades of experience across the pharmaceutical and biotechnology sectors, combining commercial leadership with deep scientific knowledge and international business expertise.
Throughout his career, he has successfully led growth initiatives, forged strategic partnerships, and expanded market presence across diverse healthcare markets.
In his new role, Eduardo will be responsible for driving commercial strategy, strengthening customer relationships, and supporting the continued growth of LMS's global operations.
His appointment comes at a time when the company is focused on enhancing its capabilities and expanding opportunities for customers and partners worldwide.
LMS believes Eduardo's extensive experience in business development and commercial excellence will play a critical role in accelerating growth and strengthening the company's position in the global CDMO and API landscape.
The company expressed confidence that his leadership will help unlock new opportunities, deepen strategic collaborations, and support the next phase of growth for Lupin Manufacturing Solutions.